Merck, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- $295.3B
- Website
- http://www.merck.ph
A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-07-30
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 27
- Registration Number
- NCT00000628
- Locations
- ๐บ๐ธ
Northwestern Univ Med School, Chicago, Illinois, United States
๐บ๐ธRush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
๐บ๐ธSan Francisco Gen Hosp, San Francisco, California, United States
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 120
- Registration Number
- NCT00002220
- Locations
- ๐บ๐ธ
Hawaii AIDS Clinical Trial Unit, Honolulu, Hawaii, United States
๐บ๐ธLAC / USC Med Ctr / Infectious Diseases, Los Angeles, California, United States
๐บ๐ธMed Ctr of Delaware, Wilmington, Delaware, United States
Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia
- Conditions
- HIV InfectionsHemophilia A
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 55
- Registration Number
- NCT00002386
- Locations
- ๐บ๐ธ
Riley Hosp for Children, Indianapolis, Indiana, United States
๐บ๐ธGeorgetown U Med Ctr / Div of Hematology / Oncology, Washington, District of Columbia, United States
๐บ๐ธEmory Univ, Atlanta, Georgia, United States
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 220
- Registration Number
- NCT00002430
- Locations
- ๐บ๐ธ
Emory Univ, Atlanta, Georgia, United States
๐บ๐ธTower ID Med Associates, Los Angeles, California, United States
๐บ๐ธAIDS Community Research Consortium, Redwood City, California, United States
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 186
- Registration Number
- NCT00002424
- Locations
- ๐บ๐ธ
UCLA School of Medicine / Ctr for Research and Education, Los Angeles, California, United States
๐บ๐ธAssociates in Research, Fort Myers, Florida, United States
๐บ๐ธRush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 200
- Registration Number
- NCT00002179
- Locations
- ๐บ๐ธ
LAC - USC Med Ctr, Los Angeles, California, United States
๐บ๐ธRush Presbyterian - Saint Luke's Med Ctr / Infect Dis, Chicago, Illinois, United States
๐บ๐ธBeth Israel Deaconess Med Ctr - East Campus, Boston, Massachusetts, United States
The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
- Conditions
- Alzheimer Disease
- First Posted Date
- 2000-08-28
- Last Posted Date
- 2009-12-11
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT00006187
- Locations
- ๐บ๐ธ
Pacific NW Clinical Research Center, Portland, Oregon, United States
๐บ๐ธUniversity of Rochester, Rochester, New York, United States
๐บ๐ธPiedmont Medical Research Associates, Winston-Salem, North Carolina, United States